| Literature DB >> 28683298 |
Rigel J Kishton1, Madhusudhanan Sukumar2, Nicholas P Restifo3.
Abstract
Cancer immunotherapy is an increasingly successful strategy for the treatment of patients who have advanced or conventional therapy-resistant cancers. T cells are key mediators of tumor destruction and their specificity for tumor-expressed antigens is of paramount importance, but other T cell-intrinsic qualities, such as durability, longevity, and functionality also play important roles in determining the efficacy of immunotherapy. The cellular energetic pathways that are utilized by T cells play a key role in regulating each of these qualities. Metabolic activity, which both regulates and is regulated by cellular signaling pathways and epigenetics, also profoundly influences the trajectories of T cell differentiation and fate. In this Review, we discuss how cell metabolism influences T cell anti-tumor activity, the metabolic qualities of highly-functional T cells, and strategies to modulate metabolism for improving the immune response to tumors. Published by Elsevier Inc.Entities:
Keywords: T cell metabolism; aging; cancer; checkpoint inhibitor; differentiation; epigenetics; immunotherapy; longevity; memory; tumor
Mesh:
Year: 2017 PMID: 28683298 PMCID: PMC5543711 DOI: 10.1016/j.cmet.2017.06.016
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287